We are a group of people dedicated to finding better treatments for neurological and psychiatric disorders like epilepsy, autism, and schizophrenia. The impact of these diseases on patients, families, and society is immense, and traditional approaches to identifying treatment have mostly failed. We’re using breakthrough technology — cerebral organoid science, systems neuroscience, robotic automation, and advanced data analytics to discover never-before-possible quantitative characterizations of these complex diseases. We call these “deep phenotypes” and use them to achieve our mission of identifying novel therapeutic targets and drug treatments. Join us.